Cvs stock forecast 2025 the CVS stock forecast 2025 also

The CVS stock forecast 2025 also factors in inflation trends, as cost pressures in drug procurement could impact margins, though diversified operations may mitigate risks. The company said it saw more prescriptions for the biosimilars in the first three weeks of April than the whole of last year, when Humira lost exclusivity in the U.S. Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market. The CVS stock forecast 2025 points toward improved ROI from in‑store clinic services, as patient convenience remains a strong competitive advantage in the healthcare retail market.